Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Financings

Cheelcare Closes $1.0 Million Unsecured Note Financing

CHER · Price

Executive Summary

  • Cheelcare Inc. closed its previously‑announced offering of 12% unsecured promissory notes, raising $1,000,000 in gross proceeds.
  • The notes were purchased by Pathfinder Asset Management Ltd. ($750,000) and NameSilo Technologies Corp. ($250,000); they bear simple interest at 12% per annum, payable semi‑annually, with principal due August 11 2027.
  • As part of the transaction, Cheelcare issued 132,450 bonus common shares (valued at 20% of the note principal) subject to a four‑month hold period; proceeds will be used for working capital, inventory, product manufacturing and general corporate purposes.

Key Details

  • Offering Size: $1,000,000 aggregate gross proceeds.
  • Note Terms:
  • Unsecured promissory notes, 12% simple annual interest, semi‑annual interest payments.
  • Principal repayment due August 11 2027; company may redeem after one year without penalty.
  • Investors:
  • Pathfinder Asset Management Ltd. – $750,000 principal amount.
  • NameSilo Technologies Corp. – $250,000 principal amount.
  • Bonus Shares:
  • 132,450 common shares issued to lenders (20% of note principal value).
  • Valued at $1.51 per share (closing price on Feb 6 2026).
  • Subject to a four‑month hold period expiring June 19 2026.
  • Use of Proceeds: Working capital, inventory acquisition, product manufacturing activities, and general corporate purposes.
  • Repayment Source: Expected cash flows from operating activities.
  • No Finders’ Fees/Commissions: None paid; lenders are arm’s‑length parties.

Notable Quotes

(No executive quotes were included in the release.)

Read the original news release →

More from Cheelcare Inc.